Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
Clinical trial NCT04849364 · TERMINATED
Trial details
- NCT number
- NCT04849364
- Sponsor
- Bryan Schneider, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2024-10-24
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.